Keyphrases
Uterine Cervical Cancer
100%
Brachytherapy
100%
In Situ Computed Tomography
100%
Working Diagnosis
40%
Overall Survival Rate
40%
Bladder
40%
Late Toxicity
40%
Local Control Rate
40%
Rectum
40%
No Significant Difference
20%
5-year Survival
20%
Magnetic Resonance Imaging
20%
Progression-free Survival
20%
Follow-up Interval
20%
Stage IB
20%
Four Fractions
20%
Local Control
20%
Advanced Stage
20%
Cervical Cancer
20%
Treatment Planning
20%
Conformal Radiotherapy
20%
External Beam Radiotherapy
20%
Cisplatin-based Chemotherapy
20%
High-risk Clinical Target Volume
20%
HDR Brachytherapy
20%
Cervical Cancer Patients
20%
Long-term Clinical Outcome
20%
Bladder Dose
20%
Central Shielding
20%
Medicine and Dentistry
Retrospective Study
100%
Cervical Cancer
100%
Brachytherapy
100%
In-Room Computed Tomography
100%
Bladder
60%
Overall Survival
40%
Survival Rate
40%
Pelvis
20%
Magnetic Resonance Imaging
20%
Progression Free Survival
20%
Cisplatin
20%
Clinical Stage
20%
Physical Examination
20%
Conformal Radiotherapy
20%
Contouring
20%
Treatment Planning
20%
External Beam Radiotherapy
20%
High-Dose-Rate Brachytherapy
20%
Chemotherapy
20%